Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells.

Campbell LA, Puolakkainen M, Lee A, Rosenfeld ME, Garrigues HJ, Kuo CC.

Microbes Infect. 2012 Jan;14(1):43-9. doi: 10.1016/j.micinf.2011.08.003. Epub 2011 Aug 30.

2.
3.
4.

GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, induces lectin-like oxidized low-density lipoprotein receptor 1 expression in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits.

Lin FY, Lin YW, Huang CY, Chang YJ, Tsao NW, Chang NC, Ou KL, Chen TL, Shih CM, Chen YH.

J Immunol. 2011 Apr 1;186(7):4405-14. doi: 10.4049/jimmunol.1003116. Epub 2011 Mar 7.

5.

Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin.

Prochnau D, Rödel J, Prager K, Kuersten D, Heller R, Straube E, Figulla HR.

Acta Microbiol Immunol Hung. 2010 Jun;57(2):147-55. doi: 10.1556/AMicr.57.2010.2.7.

PMID:
20587387
6.
7.

Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.

Hossain E, Ota A, Karnan S, Damdindorj L, Takahashi M, Konishi Y, Konishi H, Hosokawa Y.

Toxicol Appl Pharmacol. 2013 Dec 15;273(3):651-8. doi: 10.1016/j.taap.2013.10.012. Epub 2013 Oct 19.

PMID:
24145059
8.
10.

Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis.

Stancel N, Chen CC, Ke LY, Chu CS, Lu J, Sawamura T, Chen CH.

Clin Chem. 2016 Feb;62(2):320-7. doi: 10.1373/clinchem.2015.243923. Epub 2015 Nov 25. Review.

11.

Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?

Chen XP, Zhang TT, Du GH.

Cardiovasc Drug Rev. 2007 Summer;25(2):146-61. Review.

PMID:
17614937
12.

Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.

Mehta JL, Chen J, Hermonat PL, Romeo F, Novelli G.

Cardiovasc Res. 2006 Jan;69(1):36-45. Epub 2005 Dec 1. Review.

PMID:
16324688
13.

Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.

Lu J, Yang JH, Burns AR, Chen HH, Tang D, Walterscheid JP, Suzuki S, Yang CY, Sawamura T, Chen CH.

Circ Res. 2009 Mar 13;104(5):619-27. doi: 10.1161/CIRCRESAHA.108.190116. Epub 2009 Jan 15.

PMID:
19150883
14.

Prior exposure to oxidized low-density lipoprotein limits apoptosis in subsequent generations of endothelial cells by altering promoter methylation.

Mitra S, Khaidakov M, Lu J, Ayyadevara S, Szwedo J, Wang XW, Chen C, Khaidakov S, Kasula SR, Stone A, Pogribny I, Mehta JL.

Am J Physiol Heart Circ Physiol. 2011 Aug;301(2):H506-13. doi: 10.1152/ajpheart.00252.2011. Epub 2011 May 20.

15.

Oxidized LDL receptor LOX-1 binds to C-reactive protein and mediates its vascular effects.

Fujita Y, Kakino A, Nishimichi N, Yamaguchi S, Sato Y, Machida S, Cominacini L, Delneste Y, Matsuda H, Sawamura T.

Clin Chem. 2009 Feb;55(2):285-94. doi: 10.1373/clinchem.2008.119750. Epub 2008 Dec 12.

16.

Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis.

Kume N, Kita T.

Trends Cardiovasc Med. 2001 Jan;11(1):22-5. Review.

PMID:
11413048
17.

Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis.

Kume N, Kita T.

Curr Opin Lipidol. 2001 Aug;12(4):419-23. Review.

PMID:
11507327
18.

Oxidized LDL, LOX-1 and atherosclerosis.

Mitra S, Goyal T, Mehta JL.

Cardiovasc Drugs Ther. 2011 Oct;25(5):419-29. doi: 10.1007/s10557-011-6341-5. Review.

PMID:
21947818
19.
20.

LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.

Chistiakov DA, Orekhov AN, Bobryshev YV.

Cell Physiol Biochem. 2016;38(5):1851-9. doi: 10.1159/000443123. Epub 2016 May 9. Review.

Supplemental Content

Support Center